The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bartizal Ken since 2011.
The trader's CIK number is 1478832.
At the time of the last reporting, Bartizal Ken was the Chief Development Officer of Trius Therapeutics Inc. (stock ticker symbol TRSX).
Also see all insider trading activities at Trius Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | TSRX | 0 | $0 | 28,000 | $221,404 | 0 | $0 |
| 2011 | TSRX | 0 | $0 | 1,687 | $13,242 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-07-01 | TSRX | Sale | 2,000 | 8.14 | 16,280 |
| 2013-06-04 | TSRX | Sale | 2,000 | 7.90 | 15,800 |
| 2013-05-24 | TSRX | Sale | 12,000 | 7.93 | 95,124 |
| 2013-05-14 | TSRX | Sale | 12,000 | 7.85 | 94,200 |
| 2011-11-17 | TSRX | Sale | 1,687 | 7.85 | 13,242 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bartizal Ken (Chief Development Officer of Trius Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.